An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

2 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PD

NCT00209508 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GT-02287 in Parkinson's Disease

NCT06732180 ·Status: RECRUITING ·Phase: PHASE1

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Safety, Tolerability and Efficacy of E2007 in Parkinson's Disease Patients With "Wearing Off" Motor Fluctuations and "On" Period Dyskinesias

NCT01172379 ·Status: COMPLETED ·Phase: PHASE2

Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy (Depakine)

NCT00385710 ·Status: COMPLETED ·Phase: PHASE2

A Study of MK0657 in Parkinson's Disease Patients (0657-006)

NCT00505843 ·Status: COMPLETED ·Phase: PHASE1

A Study of KW-6356 in Subjects With Early Parkinson's Disease

NCT02939391 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease

NCT00558337 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease

NCT03068481 ·Status: COMPLETED ·Phase: PHASE1

Ambroxol as a Disease-modifying Treatment in GBA-PD

NCT05287503 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety, Tolerability, and Biomarker Effects of GT-02287 in Early Parkinson's Disease

NCT07280299 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Safety, Tolerability, and Plasma Concentration Study of Levodopa/Carbidopa Subcutaneous Solution (ND0612) in Parkinson's Disease (PD) Patients

NCT01725802 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability and Efficacy of MT101-5 in Subjects with Early Parkinson's Disease

NCT06175767 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations

NCT03703570 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations

NCT03670953 ·Status: COMPLETED ·Phase: PHASE3

A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease Patients

NCT00537485 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration

NCT00703677 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Tllsh2910 for Ataxia and Gut Microbiota Alteration in Patients of Multiple System Atrophy

NCT03901638 ·Status: TERMINATED ·Phase: PHASE3

A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment

NCT03713957 ·Status: COMPLETED ·Phase: PHASE2

Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Patients

NCT06189170 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia

NCT04912115 ·Status: SUSPENDED ·Phase: PHASE2

A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients

NCT02337725 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

NCT00368108 ·Status: COMPLETED ·Phase: PHASE3

A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients

NCT01628848 ·Status: COMPLETED ·Phase: PHASE2

Continuously Infused Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (GDNF) to Treat Progressive Supranuclear Palsy

NCT00005903 ·Status: COMPLETED ·Phase: PHASE2

A Study to Examine APL-130277 in Patients With Parkinson's Disease

NCT02228590 ·Status: COMPLETED ·Phase: PHASE2